Drugs for Diabetes Pain
By David Spero
Pain researcher Rebecca Sudore, MD, says, "Adults living with Type 2 diabetes are suffering from incredibly high rates of pain, at levels similar to patients living with cancer." Sounds awful. But what can we do about it? Actually, quite a bit.
Let's look at medications first. Because chronic pain involves emotions, thoughts, stress, general health, and the entire body, there are at least six different categories of drugs that can help with pain. They include: narcotics, anxiolytics (“tranquilizers"), antidepressants, anti-inflammatories, medicines for seizures, and alternative treatments.
With all tho...
Source: Diabetes Self-Management - February 6, 2013 Category: Diabetes Authors: David Spero Source Type: blogs
Glaxo Refuses To Settle With UK Avandia Patients
Although GlaxoSmithKline agreed to settle lawsuits filed in the US by people who claimed they were harmed by the controversial Avandia diabetes pill, which was linked to heart attacks and strokes, the drugmaker is reportedly refusing to adopt the same approach in the UK. Instead, Glaxo is preparing to fight at least four complaints that have so far been filed in court.
“It is very disappointing,” Daniel Slade, an attorney who represents 19 families, tells
The Guardian. “We anticipate that these claims do have a good prospect of success, but they still have to prove their case in the UK with suitable evide...
Source: Pharmalot - January 30, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Avandia GlaxoSmithKline Merck Vioxx Source Type: blogs
Avandia - the battle continues
Families face battle with GSK over dangerous diabetes drug
Thousands of families in the UK could be deprived of compensation for the death or harm of a relative caused by the diabetes drug Avandia, even though the British maker has agreed to pay billions of dollars to settle similar claims in the US.
The licence for Avandia was revoked in Europe, in September 2010, because of evidence that it could cause heart failure and heart attacks. The drug can still be prescribed in the US, but not to patients at risk of heart problems.
A scientist with the Food and Drug Administration estimated that Avandia could have been respon...
Source: PharmaGossip - January 29, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
Pipeline 2012
39 drugs approved in the USA in 2012
US Drug approvals in 2012 have reached a 15-year high with regulators giving the thumbs up to 39 new drugs.
The figures from the US Food and Drug Administration show approved drugs were up on 2011, when 30 new medicines were given marketing authorisations. Of the 39 approved in 2012, 11 were for cancer treatments and almost 20 were designated orphan drug status.
Some of the drugs allowed on the US market in 2012 included: Pfizer’s leukaemia drug Bosulif (bosutinib); Ariad Pharmaceutical’s leukaemia drug Iclusig (ponatinib); Johnson & Johnson’s multi-drug resistant TB drug Si...
Source: PharmaGossip - January 6, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
ONC and "Health IT Patient Safety Action & Surveillance Plan": When Sociologists Uphold the Hippocratic Oath While Physicians Pay Respect to the Lords of Kobol, We Are in a Dark Place, Ethically
[Note: this essay contains many hyperlinks. They can be right-clicked and opened in a separate tab or window.]I've been meaning to write more on the just-before-Christmas, Friday afternoon, minimal-visibility release of the ONC report I'd written about in my Dec. 23, 2012 post "ONC's Christmas Confessional on Health IT Safety: HIT Patient Safety Action & Surveillance Plan for Public Comment." (The ONC report itself is available at this link in PDF.)The Boston Globe and Globe staff writer Chelsea Conaboy, however, have beaten me to the punch in the Jan. 3, 2013 article "Federal government releases patient ...
Source: Health Care Renewal - January 5, 2013 Category: Health Medicine and Bioethics Commentators Tags: Cliff Rieders Chelsea Conaboy ross koppel Cybernetik Über Alles HIT Patient Safety Action and Surveillance Plan healthcare IT safety Boston Globe Ashish Jha ONC John Halamka Source Type: blogs
